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Understanding Nicotine Addiction:
Dependency as a Result of
Maladaptive Brain Structure
by Nate Thomas
Nicotine addiction is the most prevalent, destructive dependency found
in our culture. Despite its well-documented damaging health risks, nicotine
use is still widely accepted and could be conceptualized as a social epidemic. Much of this acceptance may stem from nicotine’s lack of debilitating
cognitive effects, as compared to those of other abused drugs. However,
what may reign dominantly over nicotine’s legality is simple cultural precedent: tobacco has never been illegal and holds a place in human history.
Therefore, attempting to alter this would prove highly unpopular and unsuccessful. This macroscopic irrationality, a blind favor for cultural precedents, parallels the irrational behaviors exhibited in an individual experiencing nicotine dependence. Just as the dependent brain unconditionally
craves nicotine, our culture accepts longstanding practices and traditions,
despite the contradictory state they may force upon our laws.
Humans have an extraordinary capacity for rational thought. Therefore it is expected that a rational being be capable of recognizing the dangers of chronic smoking, as this information is widely available in our
society, and cease the behavior. This contradiction of logical thought is
indicative of the existence of another, more relevant variable in the cultural summation of mass addiction. It is surmisable that this missing variable
is the dependent individual’s maladaptive brain structure, resulting from
genetics, epigenetics, and drug use.
When examining the validity of this claim, it is important to consider a variety of factors that influence the construction of an individual’s
brain. Genetics can provide a backdrop for the development of dependency. Impulsivity, for example, is a trait resulting from certain genetic coding that may be correlated with drug-seeking behaviors. Additionally, epigenetic processes can lead to heritable reorganization of genetic material
and the subsequent synthesis of proteins that expedite and exacerbate the
condition of addiction. Just as behavior can alter gene expression, there
are more direct mechanisms through which behavior can influence brain
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structure. Simply exposing one’s nicotinic acetylcholine receptors to nicotine causes immediate and progressive physiological changes, reinforcing
the addictive behaviors that cause them. However, even in light of these
considerable factors that support the concept of structural dependency, it
is important to examine other perspectives. A variety of critiques exist on
the validity of the research methods relating to specific brain function that
suggest that this data may err on the side of anecdotal evidence, which
should be taken into consideration in order to develop a full understanding of this issue.
With the supposition that nicotine addiction is a disease based in maladaptive brain structure, the specific mechanisms involved in this phenomenon must be examined. Before an individual has the opportunity
to interact with their environment, genetic diathesis can act as somewhat
of a predetermining force in the potential development of nicotine addiction. With the level of technological advancement today, correlational
data between genes and behaviors is becoming increasingly available. The
NCAM1-TTC12-ANKK1-DRD2 gene cluster located on chromosome
11q23 has been shown to be connected to nicotine dependence later on
in an individual’s life. The TTC12-ANKK1-DRD2 portion of the gene
cluster is specifically associated with impulsivity and nicotine use in adolescence (Wang, Liu, Zhang, and Zeng, 327). This finding is paramount in
determining the probability of later nicotine dependence. An adolescent’s
brain is still acutely developing, and chronic nicotine exposure causes the
brain to develop as if nicotine were another neurotransmitter. The brain,
in its natural plasticity accepts this artificial chemical stimulation and, in
a sense, expects continued stimulation in this manner. This structurally
critical period for addiction vulnerability, along with the genetic coding for
impulsive behavior, creates an individual primed by their biology to develop an addiction. Yet this presents a question: through what mechanism
can genetics change a reaction to nicotine?
The tobacco plant, as a result of natural selection, developed nicotine
as a toxic defense mechanism from insects and smaller animals. Today, tobacco persists because of artificial selection, the process describing human
involvement in natural selection. Nicotine is capable of binding to nicotinic
acetylcholine receptors (shortened to nAChRs), so named for nicotine’s
affinity for them. These receptors exist in the peripheral nervous system
at neuromuscular junctions allowing voluntary muscle contraction, and
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in the central nervous system as a part of reward, arousal, and memory
processing. A higher concentration of nAChRs in the synapses of neurons
increases sensitivity to nicotine, and in turn the likelihood to experience
dependence as an eventual result of exposure (Rahman, 352). Neurotransmitter receptors, including nAChRs, are protein molecules fixed into the
structure of a synapse between two neurons, and the synthesis of these
protein molecules is coded in DNA. Thus, the connection between nicotine sensitivity and genetic coding is obvious: genetic makeup dictates the
synthesis of nAChRs, and the concentrations of nAChRs dictates sensitivity to nicotine. This variable sensitivity between individuals results in
differing probabilities to experience dependency as a result of exposure to
nicotine. However, yet another more complex mechanism is at the root
of the heritability and persistence of the brain changes incurred through
chronic nicotine use.
A relatively new field of study, epigenetics has resulted in some sweeping changes in the understanding of the interaction of behavior and gene
expression. Once perceived as a stable trait throughout the lifespan, genetic makeup is now known to be subject to change over time. These changes
result from behavioral factors that affect the expression of genes, causing
them to become either active or inhibited. On a structural level, these alterations occur at the histone, the protein formation that DNA winds around
(Wong, Mill, and Fernandes, 481). Histone acetylation occurs when a
compound derived from acetic acid, an acetyl group, is added to a histone tail, negating its positive charge and causing gene activation (Robison
and Nestler, 629). Conversely, methylation occurs when a methyl group,
a methane-derived compound, is added to the cytosine base of a DNA
molecule, causing chromatin to be condensed and a gene to be silenced
(Wong, Mill, and Fernandes, 481). These processes can be caused by the
abuse of physically addictive substances, including nicotine (Bilinski, Wojtyla, Kapka-Skryzpzak and Chewedorowicz, 493). This modification of
genetic material is one of the most profound changes brought about by
chronic drug use, being both heritable in future generations and relatively
persistent throughout lifespan.
The processes of acetylation and methylation, in altering gene expression, alter the proteins synthesized in the body. Proteins serve a wide range
of functions, including forming some structural aspects of the brain. An
example of the persistent changes caused by these epigenetic processes is
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the synthesis of the ΔFOSB protein. Synthesis of the ΔFOSB protein, encoded by the FosB gene in the nucleus accumbens, dorsal striatum, and other
reward centers of the brain, increases as a result of nicotine use. One of
the functions of this protein is to regulate sensitivity of these brain areas to
the rewarding aspects of drugs of abuse (Renthal and Nestler, 341). ΔFOSBis a truncated version of the FOSB protein that, because of its shortened
length, is four times as stable as the normally synthesized protein (Renthal
and Nestler, 348). This stability causes the behavioral deviations it creates
to be highly persistent, even after nicotine cessation, as the protein remains
active in the brain’s motivational systems. These long-standing changes
indicate that irrational, addictive behaviors are, at their root, a result of
maladaptive brain structure.
While epigenetic processes cause persistent alterations over a course of
chronic abuse, there are other mechanisms that cause acute brain changes
as a result of severe exposure. As opposed to the complex epigenetic mechanisms involved in drug addiction, drug induced structural alterations of
the brain are more direct and intuitive changes, acting directly on the receptors to which the drug binds. Exposure to nicotine causes upregulation
(an increase in abundance) of the a4b2 subtype of nicotinic acetylcholine
receptors (Govind, Vezina, and Green, 757). This partially explains craving behaviors caused by nicotine use, as the brain seeks to activate these
newly formed receptors. While this would also seem to imply an increase
in sensitivity as the addiction progresses, another simultaneous mechanism compensates for this. In addition to upregulation, nicotine exposure
causes desensitization of the same a4b2 subtype of nAChRs, making them
less responsive to all forms of stimulation (Govind, Vezina, and Green,
758). This phenomenon is more commonly known as tolerance. As the
brain experiences upregulation of nAChRs, it craves to have them activated while experiencing a diminished reward as a result of desensitization.
This diminished reward system activation, in those prone to addiction,
can result in increased administration as well as administration at higher dosages to circumvent a reduction in perceived effect. Behaviors with
their roots in dysfunctional brain structure can quickly spawn a physical
dependence as these processes cause consumption to spiral out of control.
Thus, when attempting to stop consumption, the aversive effects involved
with the cessation of nicotine, known as withdrawal symptoms, pose significant challenges.
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Withdrawal symptoms, a phenomenon isolated to physically addictive
drugs of abuse, are the most common and outwardly visible indication of
the genesis of dependence. These effects of chronic substance abuse vary
in severity, depending on the drug involved, from simple mood and concentration disturbances to life threatening health complications. Nicotine
withdrawal is markedly unpleasant, causing symptoms of irritability, anxiety, and depression. However, these factors are placated by the lack of a
life-endangering component in the cessation of smoking. Despite the relative safety of nicotine withdrawal, it is the preventative force in the efforts
of many seeking to cease smoking behaviors. In the absence of nicotine,
the dependent brain experiences withdrawal symptoms until either enough
time is allotted for the brain to naturally down-regulate and re-sensitize the
afflicted nAChRs, or the individual consumes more nicotine (Ortells and
Barrantes, 889). The latter option is a much more common response as
this behavior is supported by a plethora of other aforementioned structural factors. Furthermore the relief it provides is instant, which enforces
the mental association of reprieve from negative mood states and nicotine
administering behaviors, thereby strengthening the addiction. With these
concepts in mind, it becomes clear that withdrawal symptoms are a structurally-based phenomenon, the result of the physical processes of upregulation and desensitization. However, from a different perspective, chronic
addictive behaviors stem from the rewiring of the brain’s reward system.
Closely tied to the function of this motivational system is the neurotransmitter, dopamine.
Dopamine release has long been understood to be involved in the consumption of abused drugs. This neurotransmitter is associated with physically rewarding stimuli, encouraging the consumption of high fat foods and
the procreation of our species. In the context of drug use, dopamine reinforces addictive behaviors by activating the same brain circuits designed to
motivate an individual to eat and reproduce. Nicotine’s rewarding effects
stem from activation of the mesocorticolimibic dopamine system, which
projects to the nucleus accumbens and other areas of the forebrain. Dopamine release in the nucleus accumbens is present universally in physically addictive substances, demonstrating a strong correlation between this
activation and addiction. Defying the intuitive implications of dopamine
release in this brain area, chronic nicotine use causes lower overall levels
of dopamine in the nucleus accumbens, as the process of reuptake is accel-
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erated to compensate for heightened dopamine release in the presence of
nicotine (Ortelles and Barrantes, 890). This contributes to the depressive
symptoms associated with withdrawal, as an imbalance in dopamine levels
is a primary cause of depression. The implications of the various dopamine pathways’ involvement in drug addiction are critical to the perceived
need to consume nicotine. The way in which one experiences a reward
for fulfilling an appetite for food parallels the way a dependent individual
experiences a reward for fulfilling a craving for nicotine, as the rewarding
aspects of both behaviors stem from the same system. Nicotine’s ability to
essentially hijack and rewire an individual’s behavioral motivation system
is central to its addictive qualities. Through the modification of dopamine
pathways, there is yet another prevalent, structural factor contributing to
nicotine dependence.
As discussed earlier, upregulation and desensitization are central to the
experience of nicotine’s withdrawal symptoms. One may expect that the
effects of desensitization would eventually leave one’s nAChRs wholly unresponsive to stimulation, negating the condition of nicotine dependence.
However, this is clearly not the case since those experiencing nicotine dependence would eventually reach such a point of dependency that the
addiction would not progress further. NAChRs on dopaminergic neurons
are not fully desensitized by nicotine, allowing their continued activation
from the consumption of nicotine (Ortells and Barrantes, 887). Additionally, nicotine can indirectly stimulate dopamine release in the ventral tegemental area, another area critical to reward processing, through the a7
subtype of nAChRs. This particular subtype of receptor is less affected by
upregulation and desensitization (Ortells and Barrantes, 888). The resistance to upregulation and desensitization, along with dopaminergic neurons’ resistance to desensitization, allots two mechanisms through which
nicotine can continue to stimulate dopamine release even after the brain
has begun to develop a tolerance to the chemical. Continuous dopamine
release as a result of nicotine prevents progressive tolerance from breaking
the association between nicotine consumption and a chemical reward. At
their root, these mechanisms represent another means through which maladaptive brain structure holds influence over behaviors associated with
drug addiction. Even considering all of the preceding support for the supposition that addiction is a result of maladaptive brain structure, it is still
important to consider some dissenting perspectives.
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As with any field of study, there exists a variety of viewpoints that
lend themselves to questioning the validity of research findings, and biopsychology is no exception. A necessary, but strikingly limiting factor in
psychological research, is the ethical concerns about how research is conducted. These concerns prevent a vast array of research on human subjects from being conducted, even under the pretense that these subjects are
selected on a volunteer basis. As such, research on the effects of drugs and
their addictive potential is conducted on creatures of a lower trophic level, generally rats because of their relatively short lifespan. This relatively
short life span allows for much more productive genetic research, as the
effects of heredity are seen within a period of a few years. However, the
complications of using animals for these types of research procedures are
presented when one considers the concept of self-administration, something critical to drug addiction. Studies done on non-human animals related to addiction lack a component of self-administration, as these animals
are not consciously aware of the substances they are made to consume
(Kalant, 781). This may call into question the findings of research conducted in this manner, as generalizing knowledge ascertained from animal
studies to human biological structures could be considered extrapolative.
Considering that much of the research on structural adaptations of the
brain during drug addiction involve non-human animal subjects, this is
certainly a troublingpredicament.
Methodology aside, when examining the findings themselves, more
problems with our understanding become apparent. The human nervous
system is incredibly complex; it acts comparably to our own global economic system, in that it is an interwoven web of activity that is inseparable
from itself. One structure’s activity could not exist without the activity of
the other’s, and herein lies the issue at hand. The changes related to drug
addiction affect so many different brain structures and neurotransmitters
that drawing specific conclusions can quickly err into the realm of generalizations and simplification. Take dopamine as an example, which has
long been heralded as a neurotransmitter integrally connected to reward
experience. In some studies, dopamine has been shown to not be directly
connected to the experience of reward, but to exposure to novel stimuli.
Rather, the reward experience is a result of the action of a variety of neurotransmitters, neuromodulators, and other factors (Kalant, 783). With
the connection between dopamine and reward undermined, it is easy to
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see how much of the research surrounding addiction can be refuted, or
perceived as correlational data. Problems of this nature also surround genetic research on drug addiction. Genes shown to be connected to drug
addiction are also associated with a large number of other responses to
stimuli, weakening the connection between gene and behavior to a correlation (Kalant, 783). While correlational evidence still implies a connection,
any mass of correlations does not equate to causation. However, despite
these discrepancies, the correlational and practical support for drug addiction having a considerable structural basis remains.
The behaviors common to drug addiction in humans represent an incredibly prevalent transgression against our capacity for rational thought.
In most other circumstances where an individual’s long-term health is
brought into question, the course of action is clear: eliminate the aversive
stimulus. With drug addiction, while the correct course of action may be
known, ceasing the health-damaging behaviors can be insurmountably difficult. The difficulty with this demonstrates some alteration of the system
that decisions stem from the brain. Working from the supposition that
nicotine addiction is the result of maladaptive brain structure could open
the pathway to more effective treatments for addiction. For a treatment to
be effective, it is critical to understand what specifically causes the ailment.
Perhaps future approaches to the treatment of nicotine addiction could
center on the processes of upregulation and desensitization, thereby alleviating withdrawal symptoms associated with cessation. If effective treatments for this condition could be properly implemented, a huge number
of premature deaths could be prevented and the quality of life of many
would be vastly improved.
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